Neuroimaging advances regarding subjective cognitive decline in preclinical Alzheimer’s disease
Neuroimaging advances regarding subjective cognitive decline in preclinical Alzheimer’s disease
About this item
Full title
Author / Creator
Wang, Xiaoqi , Huang, Weijie , Su, Li , Xing, Yue , Jessen, Frank , Sun, Yu , Shu, Ni and Han, Ying
Publisher
London: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
London: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Subjective cognitive decline (SCD) is regarded as the first clinical manifestation in the Alzheimer’s disease (AD) continuum. Investigating populations with SCD is important for understanding the early pathological mechanisms of AD and identifying SCD-related biomarkers, which are critical for the early detection of AD. With the advent of advanced...
Alternative Titles
Full title
Neuroimaging advances regarding subjective cognitive decline in preclinical Alzheimer’s disease
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_f40ff66c20da4d0c80708c1e6580b940
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_f40ff66c20da4d0c80708c1e6580b940
Other Identifiers
ISSN
1750-1326
E-ISSN
1750-1326
DOI
10.1186/s13024-020-00395-3
